HK1084029A1 - Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain - Google Patents

Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain

Info

Publication number
HK1084029A1
HK1084029A1 HK06104385.9A HK06104385A HK1084029A1 HK 1084029 A1 HK1084029 A1 HK 1084029A1 HK 06104385 A HK06104385 A HK 06104385A HK 1084029 A1 HK1084029 A1 HK 1084029A1
Authority
HK
Hong Kong
Prior art keywords
carboxymethyl
gastro
carboxylate
cyano
amino
Prior art date
Application number
HK06104385.9A
Other languages
English (en)
Inventor
Yannis Tsouderos
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1084029A1 publication Critical patent/HK1084029A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK06104385.9A 2002-11-05 2006-04-11 Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain HK1084029A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213805A FR2846558B1 (fr) 2002-11-05 2002-11-05 Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
PCT/FR2003/003279 WO2004043455A1 (fr) 2002-11-05 2003-11-04 Utilisation du sel distrontique de l'acide 2-[n,n-di(carboxymethyl)amino]-3-cyano-4-carboxymethyl-thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales

Publications (1)

Publication Number Publication Date
HK1084029A1 true HK1084029A1 (en) 2006-07-21

Family

ID=32104443

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06104385.9A HK1084029A1 (en) 2002-11-05 2006-04-11 Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain

Country Status (26)

Country Link
US (1) US7544710B2 (xx)
EP (1) EP1560578B1 (xx)
JP (1) JP4335146B2 (xx)
KR (1) KR100735348B1 (xx)
CN (1) CN1705479B (xx)
AT (1) ATE328591T1 (xx)
AU (1) AU2003292325B2 (xx)
BR (1) BR0315917A (xx)
CA (1) CA2503975C (xx)
CY (1) CY1105105T1 (xx)
DE (1) DE60305962T2 (xx)
DK (1) DK1560578T3 (xx)
EA (1) EA007863B1 (xx)
ES (1) ES2264010T3 (xx)
FR (1) FR2846558B1 (xx)
GE (1) GEP20084463B (xx)
HK (1) HK1084029A1 (xx)
MA (1) MA27406A1 (xx)
MX (1) MXPA05004792A (xx)
NO (1) NO333599B1 (xx)
NZ (1) NZ539516A (xx)
PL (1) PL214704B1 (xx)
PT (1) PT1560578E (xx)
UA (1) UA78618C2 (xx)
WO (1) WO2004043455A1 (xx)
ZA (1) ZA200503082B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1534305T3 (pl) 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
WO2005123098A2 (en) * 2004-06-17 2005-12-29 Osteologix A/S Preventing gastrointestinal side-effects with strontium salts
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
FR2749759B1 (fr) * 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
US6489356B2 (en) * 2000-09-05 2002-12-03 Edward Leung Method for treating pain in humans

Also Published As

Publication number Publication date
PL214704B1 (pl) 2013-09-30
ATE328591T1 (de) 2006-06-15
CA2503975C (fr) 2010-05-25
AU2003292325B2 (en) 2008-07-31
ZA200503082B (en) 2006-07-26
WO2004043455A1 (fr) 2004-05-27
GEP20084463B (en) 2008-08-25
NO333599B1 (no) 2013-07-22
JP4335146B2 (ja) 2009-09-30
AU2003292325A1 (en) 2004-06-03
KR20050072476A (ko) 2005-07-11
EA200500687A1 (ru) 2005-10-27
KR100735348B1 (ko) 2007-07-04
NZ539516A (en) 2007-11-30
DE60305962D1 (de) 2006-07-20
EA007863B1 (ru) 2007-02-27
CN1705479A (zh) 2005-12-07
FR2846558B1 (fr) 2006-07-14
UA78618C2 (uk) 2007-04-10
MXPA05004792A (es) 2005-07-22
ES2264010T3 (es) 2006-12-16
DK1560578T3 (da) 2006-10-02
CY1105105T1 (el) 2009-11-04
PL375960A1 (en) 2005-12-12
DE60305962T2 (de) 2007-02-08
EP1560578B1 (fr) 2006-06-07
NO20052562L (no) 2005-05-26
PT1560578E (pt) 2006-09-29
FR2846558A1 (fr) 2004-05-07
CN1705479B (zh) 2010-04-28
MA27406A1 (fr) 2005-06-01
BR0315917A (pt) 2005-09-20
US7544710B2 (en) 2009-06-09
EP1560578A1 (fr) 2005-08-10
JP2006508112A (ja) 2006-03-09
US20060014824A1 (en) 2006-01-19
CA2503975A1 (fr) 2004-05-27

Similar Documents

Publication Publication Date Title
IL165264A (en) Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
TW200505881A (en) Tri(cyclo) substituted amide compounds
DE60015112T8 (de) Peptidextrakt aus lupinen und pharmazeutische oder kosmetische oder pharmaco-nahrungsmittel zusammensetzung, die so ein extrakt enthalten
IL166833A (en) 2-arylthiazole compounds, process for their preparation and use thereof in the preparation of medicaments for the treatment of diseases modulated by pparalpha and ppargamma agonists
HK1084029A1 (en) Use of the distrontium salt of the acid 2-[n,n-di(carboxymethyl)amino]-3- cyano-4-carboxymethyl-thiophene-5-carboxylate for the production of medicaments for the treatment of gastro-duodenal pain
HK1075843A1 (en) 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
FR2848428B1 (fr) Composition cosmetique et procede pour le traitement des matieres keratiniques, comprenant un compose photodimerisable
IL163951A0 (en) New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine
DE60312969D1 (de) Zubereitung für die wundheilung und zur verhinderung des anhaftens von verbänden an die wunde
EP1422240A3 (en) Analogs of nociceptin
WO2004016741A3 (en) Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
HUP0401773A3 (en) Use of [(2-amino-3,4-dioxo-1cyclobuten-1-yl)amino]alkanacid derivatives for the preparation pharmaceutical compositions usable for treatment of pain
PL1697005T3 (pl) Kombinacja flupirtyny i tramadolu
AU2003303217A8 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
MXPA05006408A (es) Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
EA200401454A1 (ru) Новая комбинация из обратимо действующих ингибиторов протонного насоса и используемых в терапии дыхательных путей лекарственных веществ, предназначенных для лечения респираторных заболеваний
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
SI1560578T1 (sl) Uporaba distroncijeve soli 2-(n,n-di(karboksimetil)amino)-3-ciano-4- karboksimetiltiofen-5-karboksilne kisline za pripravo zdravil za zdravljenje gastro-duodenalnih bolecin
PT1572686E (pt) Derivados de amida do ácido antranílico e suas utilizações farmacêuticas
AU2003244636A1 (en) Hair care composition
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
SI1474415T1 (sl) 1-fenil-2-heteroaril-substituirani derivati benzimidazola, njihova uporaba za izdelavo zdravil za zdravljenje imunoloških bolezni
UA90843C2 (ru) Соединения три(цикло)-замещенных амидов
EP1509240A4 (en) IDENTIFICATION OF ANTIGENS OF ACTINOBACILLUS ACTINOMYCETEMCOMITANS USED IN THE DIAGNOSIS, TREATMENT AND MONITORING OF PERIODONTAL DISEASES
PL370839A1 (en) Use of proton pump inhibitors for the treatment of airway disorders

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161104